NCT05523687View on ClinicalTrials.gov

AME Study of [14C]-PC14586 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 6, 2022

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Healthy Male Volunteers
Interventions
DRUG

[14C]-PC14586

Single, oral dose of \[14C\]-PC14586

Trial Locations (1)

53704

Labcorp Clinical Research Unit Inc., Madison

Sponsors
All Listed Sponsors
lead

PMV Pharmaceuticals, Inc

INDUSTRY